Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
出版年份 2020 全文链接
标题
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
作者
关键词
-
出版物
Cancers
Volume 12, Issue 6, Pages 1668
出版商
MDPI AG
发表日期
2020-06-24
DOI
10.3390/cancers12061668
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Emerging Roles of Exosomes in the Chemoresistance of Hepatocellular Carcinoma
- (2020) Jie Zhang et al. CURRENT MEDICINAL CHEMISTRY
- A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma
- (2020) Yilu Feng et al. Cell Death & Disease
- TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway
- (2020) Yanfeng Liu et al. Nature Communications
- Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice
- (2020) Sharmilla Devi Jayasingam et al. Frontiers in Oncology
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- HIF1A activates the transcription of lncRNA RAET1K to modulate hypoxia-induced glycolysis in hepatocellular carcinoma cells via miR-100-5p
- (2020) Yufan Zhou et al. Cell Death & Disease
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells
- (2019) Giuseppe Vassalli Stem Cells International
- Cabozantinib: A Review in Advanced Hepatocellular Carcinoma
- (2019) Emma D. Deeks Targeted Oncology
- Targeting PI3K in cancer: mechanisms and advances in clinical trials
- (2019) Jing Yang et al. Molecular Cancer
- Targeting the ROS/PI3K/AKT/HIF‐1α/HK2 axis of breast cancer cells: Combined administration of Polydatin and 2‐Deoxy‐d‐glucose
- (2019) Tao Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Functional role of SGK3 in PI3K/Pten driven liver tumor development
- (2019) Hui Cao et al. BMC CANCER
- Oxidative Stress-Driven Autophagy acROSs Onset and Therapeutic Outcome in Hepatocellular Carcinoma
- (2019) Fabio Ciccarone et al. Oxidative Medicine and Cellular Longevity
- The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
- (2019) Kalijn F. Bol et al. Journal for ImmunoTherapy of Cancer
- The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells
- (2019) Li Wang et al. OncoTargets and Therapy
- Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
- (2019) Selena Vigano et al. Frontiers in Immunology
- New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma
- (2019) Mossenta et al. Cancers
- Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma
- (2019) Mi Na Kim et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- Basil polysaccharide inhibits hypoxia-induced hepatocellular carcinoma metastasis and progression through suppression of HIF-1α-mediated epithelial-mesenchymal transition
- (2019) Bing Feng et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors
- (2019) Aasen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A global view of hepatocellular carcinoma: trends, risk, prevention and management
- (2019) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- Expressions of Carbohydrate Response Element Binding Protein and Glucose Transporters in Liver Cancer and Clinical Significance
- (2019) Yu Lei et al. PATHOLOGY & ONCOLOGY RESEARCH
- Diclofenac Potentiates Sorafenib-Based Treatments of Hepatocellular Carcinoma by Enhancing Oxidative Stress
- (2019) Duval et al. Cancers
- CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma
- (2019) Shigeki Suemura et al. Cancers
- The Redox Role of G6PD in Cell Growth, Cell Death, and Cancer
- (2019) Yang et al. Cells
- Targeted inhibition of MCT4 disrupts intracellular pH homeostasis and confers self-regulated apoptosis on hepatocellular carcinoma
- (2019) Youbo Zhao et al. EXPERIMENTAL CELL RESEARCH
- Hypoxia‑inducible factors in hepatocellular carcinoma (Review)
- (2019) Yang Guo et al. ONCOLOGY REPORTS
- Glypican-3 Enhances Reprogramming of Glucose Metabolism in Liver Cancer Cells
- (2019) Gebing Yao et al. Biomed Research International
- Models for Understanding Resistance to Chemotherapy in Liver Cancer
- (2019) Jose J. G. Marin et al. Cancers
- Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
- (2019) Karen G. de la Cruz-López et al. Frontiers in Oncology
- Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets
- (2019) Joanna Kopecka et al. DRUG RESISTANCE UPDATES
- Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells
- (2019) Carolina Méndez-Blanco et al. Cancers
- miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA
- (2018) Shengni Hua et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Insulin specifically regulates expression of liver and muscle phosphofructokinase isoforms
- (2018) Priscila Ausina et al. BIOMEDICINE & PHARMACOTHERAPY
- Targeting FBPase is an emerging novel approach for cancer therapy
- (2018) Gao-Min Liu et al. Cancer Cell International
- Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways
- (2018) Yufu Tang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Redundant angiogenic signaling and tumor drug resistance
- (2018) Rajesh N. Gacche et al. DRUG RESISTANCE UPDATES
- Targeting the CD73-adenosine axis in immuno-oncology
- (2018) David Allard et al. IMMUNOLOGY LETTERS
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- MicroRNA‑34a inhibits liver cancer cell growth by reprogramming glucose metabolism
- (2018) Hai‑Feng Zhang et al. Molecular Medicine Reports
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low glucose metabolism in hepatocellular carcinoma with GPC3 expression
- (2018) You-Cai Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Role of microRNAs in the main molecular pathways of hepatocellular carcinoma
- (2018) Francesco Vasuri et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Autophagy activation contributes to glutathione transferase Mu 1‑mediated chemoresistance in hepatocellular carcinoma
- (2018) Xiu‑Tao Fu et al. Oncology Letters
- Inhibition of the PI3K/Akt signaling pathway reverses sorafenib‑derived chemo‑resistance in hepatocellular carcinoma
- (2018) Hao Zhang et al. Oncology Letters
- The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer
- (2018) Juan M. Barajas et al. Scientific Reports
- The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues
- (2018) Eric S. Goetzman et al. Frontiers in Endocrinology
- Targeting adenosine for cancer immunotherapy
- (2018) Robert D. Leone et al. Journal for ImmunoTherapy of Cancer
- Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer
- (2018) Nikos Koundouros et al. Frontiers in Oncology
- Identification of a co-target for enhancing efficacy of sorafenib in HCC through a quantitative modeling approach
- (2018) Madhulika Mishra et al. FEBS Journal
- Caveolin enhances hepatocellular carcinoma cell metabolism, migration, and invasion in vitro via a hexokinase 2-dependent mechanism
- (2018) Fang Chai et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Molecular therapies and precision medicine for hepatocellular carcinoma
- (2018) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Prognostic significance of NANOG expression in solid tumors: a meta-analysis
- (2018) Lingqiong Zhao et al. OncoTargets and Therapy
- Targeting Adenosine Receptor Signaling in Cancer Immunotherapy
- (2018) Kevin Sek et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Glutathione Transferases: Potential Targets to Overcome Chemoresistance in Solid Tumors
- (2018) Marija Pljesa-Ercegovac et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hypoxia‐inducible factor‐2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin
- (2018) Miao He et al. Molecular Oncology
- The ERK and JNK pathways in the regulation of metabolic reprogramming
- (2018) Salvatore Papa et al. ONCOGENE
- Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
- (2018) Serena De Matteis et al. Oxidative Medicine and Cellular Longevity
- Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma
- (2018) Ruiqi Liu et al. CANCER LETTERS
- Glyceraldehyde-3-phosphate dehydrogenase promotes liver tumorigenesis by modulating phosphoglycerate dehydrogenase
- (2017) Shanshan Liu et al. HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
- (2017) Fubo Zhou et al. MEDICINAL RESEARCH REVIEWS
- Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells
- (2017) Jiejie Dong et al. PLoS One
- Oncogenic Activities of IDH1/2 Mutations: From Epigenetics to Cellular Signaling
- (2017) Laurence M. Gagné et al. TRENDS IN CELL BIOLOGY
- Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation
- (2017) Xue-li Bian et al. Nature Communications
- Hypoxia inducible factors in hepatocellular carcinoma
- (2017) Chu Chen et al. Oncotarget
- BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats
- (2017) Dapeng Wang et al. Scientific Reports
- The emerging role and targetability of the TCA cycle in cancer metabolism
- (2017) Nicole M. Anderson et al. Protein & Cell
- Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma
- (2017) Parvin Zamani et al. Artificial Cells Nanomedicine and Biotechnology
- Combined Inhibitions of Glycolysis and AKT/autophagy Can Overcome Resistance to EGFR-targeted Therapy of Lung Cancer
- (2017) Mingtong Ye et al. Journal of Cancer
- Changes of Oxidative Stress, Glutathione, and Its Dependent Antioxidant Enzyme Activities in Patients with Hepatocellular Carcinoma before and after Tumor Resection
- (2017) Shao-Bin Cheng et al. PLoS One
- P-100Phase IB study of sorafenib + evofosfamide in patients (pts) with advanced hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC): NCCTG N1153 (Alliance)
- (2016) M. Borad et al. ANNALS OF ONCOLOGY
- The Warburg effect: 80 years on
- (2016) Michelle Potter et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma
- (2016) H. Hirata et al. CANCER RESEARCH
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism
- (2016) Chia-Lin Chen et al. Cell Metabolism
- Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer
- (2016) Rafael Duran et al. CLINICAL CANCER RESEARCH
- Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics
- (2016) Ruud H. Wijdeven et al. DRUG RESISTANCE UPDATES
- Lysosomes as mediators of drug resistance in cancer
- (2016) Benny Zhitomirsky et al. DRUG RESISTANCE UPDATES
- HKDC1 Is a Novel Hexokinase Involved in Whole-Body Glucose Use
- (2016) Anton E. Ludvik et al. ENDOCRINOLOGY
- Oxidative Stress and Liver Cancer: Etiology and Therapeutic Targets
- (2016) Zhanpeng Wang et al. Oxidative Medicine and Cellular Longevity
- Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects
- (2016) Run-Ze Shang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
- (2016) Yukihiro Haruyama WORLD JOURNAL OF GASTROENTEROLOGY
- 2-Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells
- (2016) Minoru Tomizawa et al. Oncology Letters
- AMPK and PKA interaction in the regulation of survival of liver cancer cells subjected to glucose starvation
- (2016) Anabela C. Ferretti et al. Oncotarget
- Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New
- (2016) Luca Faloppi et al. Biomed Research International
- Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells – Role of Anchored Protein Kinase A Signaling Units
- (2016) Vanessa L. Wehbi et al. Frontiers in Immunology
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways
- (2016) Thomas Thurnherr et al. Scientific Reports
- Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma
- (2015) Mingxin Zhang et al. BMC CANCER
- Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach
- (2015) Sophie Taylor et al. DRUG RESISTANCE UPDATES
- Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis
- (2015) Patrizia Zavattari et al. HEPATOLOGY
- Regulation of NANOG in cancer cells
- (2015) Shuai Gong et al. MOLECULAR CARCINOGENESIS
- Targeting hypoxia-inducible factor-2α enhances sorafenib antitumor activity via β-catenin/C-Myc-dependent pathways in hepatocellular carcinoma
- (2015) FENG LIU et al. Oncology Letters
- miR-125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway
- (2015) HAO TANG et al. Oncology Letters
- Stratification of Hepatocellular Carcinoma Patients Based on Acetate Utilization
- (2015) Elias Björnson et al. Cell Reports
- Co-Inhibition of GLUT-1 Expression and the PI3K/Akt Signaling Pathway to Enhance the Radiosensitivity of Laryngeal Carcinoma Xenografts In Vivo
- (2015) Xing-Mei Luo et al. PLoS One
- Glyceraldehyde-3-Phosphate Dehydrogenase: A Promising Target for Molecular Therapy in Hepatocellular Carcinoma
- (2015) Shanmugasundaram Ganapathy-Kanniappan et al. Oncotarget
- Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing
- (2015) Filip Janku et al. Oncotarget
- Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update
- (2014) Qingcheng Mao et al. AAPS Journal
- Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma
- (2014) Anthony W. Tolcher et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells
- (2014) Dali Zhao et al. CELLULAR SIGNALLING
- A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected Advanced Solid Tumors
- (2014) P. L. Bedard et al. CLINICAL CANCER RESEARCH
- ROS Function in Redox Signaling and Oxidative Stress
- (2014) Michael Schieber et al. CURRENT BIOLOGY
- Evidence for Heightened Hexokinase II Immunoexpression in Hepatocyte Dysplasia and Hepatocellular Carcinoma
- (2014) Grace Guzman et al. DIGESTIVE DISEASES AND SCIENCES
- Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
- (2014) Shanshan Wan et al. GASTROENTEROLOGY
- Upregulation of CD147 protects hepatocellular carcinoma cell from apoptosis through glycolytic switch via HIF-1 and MCT-4 under hypoxia
- (2014) Xia Ke et al. Hepatology International
- Influence of preoperative transcatheter arterial chemoembolization on gene expression in the HIF-1α pathway in patients with hepatocellular carcinoma
- (2014) Weiguang Xu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma
- (2014) Akinobu Ohno et al. LIVER INTERNATIONAL
- Nucleotide signalling during inflammation
- (2014) Marco Idzko et al. NATURE
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- miR-122 Targets Pyruvate Kinase M2 and Affects Metabolism of Hepatocellular Carcinoma
- (2014) Angela M. Liu et al. PLoS One
- HIF-1α and HIF-2α: Siblings in Promoting Angiogenesis of Residual Hepatocellular Carcinoma after High-Intensity Focused Ultrasound Ablation
- (2014) Lun Wu et al. PLoS One
- AMP-Activated Protein Kinase Suppresses the In Vitro and In Vivo Proliferation of Hepatocellular Carcinoma
- (2014) Jidong Cheng et al. PLoS One
- Switching of Pyruvate Kinase Isoform L to M2 Promotes Metabolic Reprogramming in Hepatocarcinogenesis
- (2014) Carmen Chak-Lui Wong et al. PLoS One
- Dual Pharmacological Targeting of the MAP Kinase and PI3K/mTOR Pathway in Preclinical Models of Colorectal Cancer
- (2014) Todd M. Pitts et al. PLoS One
- The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma
- (2014) Dongjun Luo et al. Biomed Research International
- Role of Nrf2 in Oxidative Stress and Toxicity
- (2013) Qiang Ma Annual Review of Pharmacology and Toxicology
- Regulatory T-cells and cAMP suppress effector T-cells independently of PKA–CREM/ICER: a potential role for Epac
- (2013) Amanda G. Vang et al. BIOCHEMICAL JOURNAL
- PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis
- (2013) Xuehui Hong et al. GUT
- Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma
- (2013) Yingjian Liang et al. HEPATOLOGY
- Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520
- (2013) Yun-Yong Park et al. HEPATOLOGY
- Identification of driver genes in hepatocellular carcinoma by exome sequencing
- (2013) Sean P. Cleary et al. HEPATOLOGY
- Lactate dehydrogenase a in cancer: A promising target for diagnosis and therapy
- (2013) Ping Miao et al. IUBMB LIFE
- The Correlation of Expression Levels of HIF-1 and HIF-2 in Hepatocellular Carcinoma with Capsular Invasion, Portal Vein Tumor Thrombi and Patients' Clinical Outcome
- (2013) S.-L. Yang et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy
- (2013) I-Pei Chen et al. JOURNAL OF GASTROENTEROLOGY
- Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends
- (2013) Matthias S. Matter et al. JOURNAL OF HEPATOLOGY
- Tumor-Derived Lactate Modifies Antitumor Immune Response: Effect on Myeloid-Derived Suppressor Cells and NK Cells
- (2013) Z. Husain et al. JOURNAL OF IMMUNOLOGY
- Expression and Correlation of Hypoxia-inducible Factor-1α, Vascular Endothelial Growth Factor and Microvessel Density in Experimental Rat Hepatocarcinogenesis
- (2013) W Wang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Macrophage biology in development, homeostasis and disease
- (2013) Thomas A. Wynn et al. NATURE
- Role of Glutathione in Cancer Progression and Chemoresistance
- (2013) Nicola Traverso et al. Oxidative Medicine and Cellular Longevity
- Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
- (2013) Jiri Polivka et al. PHARMACOLOGY & THERAPEUTICS
- Oxidative stress and cancer: An overview
- (2012) Venus Sosa et al. AGEING RESEARCH REVIEWS
- Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma
- (2012) Caecilia HC Sukowati et al. BMC GASTROENTEROLOGY
- Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma
- (2012) S Hagiwara et al. BRITISH JOURNAL OF CANCER
- AMPK Promotes p53 Acetylation via Phosphorylation and Inactivation of SIRT1 in Liver Cancer Cells
- (2012) C.-W. Lee et al. CANCER RESEARCH
- Hypoxia-Inducible Factors in Physiology and Medicine
- (2012) Gregg L. Semenza CELL
- Orchestration of Metabolism by Macrophages
- (2012) Subhra K. Biswas et al. Cell Metabolism
- Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma
- (2012) Shi L. Sheng et al. FEBS Journal
- Aldehyde dehydrogenases in cellular responses to oxidative/electrophilicstress
- (2012) Surendra Singh et al. FREE RADICAL BIOLOGY AND MEDICINE
- MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma
- (2012) YuXiang Fang et al. HEPATOLOGY
- A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancer
- (2012) Sil Kordes et al. INVESTIGATIONAL NEW DRUGS
- Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury
- (2012) Li Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
- (2012) Nicole Grabinski et al. Molecular Cancer
- Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
- (2012) Cécile Guichard et al. NATURE GENETICS
- Iron facilitator LS081 reduces hypoxia-inducible factor-1α protein and functions as anticancer agent in hepatocellular carcinoma
- (2011) Hiroki Tanaka et al. CANCER SCIENCE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
- (2011) S. Ryzhov et al. JOURNAL OF IMMUNOLOGY
- Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview
- (2011) Monica Marra et al. Journal of Translational Medicine
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
- (2011) Gina M. DeNicola et al. NATURE
- The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
- (2011) Maria M. Mihaylova et al. NATURE CELL BIOLOGY
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
- (2011) Michelle C. Mendoza et al. TRENDS IN BIOCHEMICAL SCIENCES
- Glypican 3 binds to GLUT1 and decreases glucose transport activity in hepatocellular carcinoma cells
- (2010) Hye-Sim Cho et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma
- (2010) Julja Burchard et al. Molecular Systems Biology
- Regulation and Cytoprotective Role of Hexokinase III
- (2010) Eugene Wyatt et al. PLoS One
- Mitogen-activated protein kinases in hepatocellular carcinoma development
- (2010) Lihua Min et al. SEMINARS IN CANCER BIOLOGY
- GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis
- (2009) Thomas Amann et al. AMERICAN JOURNAL OF PATHOLOGY
- Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery
- (2009) Chen-Xin Dai et al. BMC CANCER
- Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma
- (2009) Hirofumi Shirakawa et al. CANCER SCIENCE
- Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9
- (2009) Jing-song Chen et al. HEPATOLOGY RESEARCH
- HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection
- (2009) Yu Li et al. HISTOPATHOLOGY
- RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growthin vitroandin vivo
- (2009) Luc Gailhouste et al. INTERNATIONAL JOURNAL OF CANCER
- Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo
- (2009) Pippa Newell et al. JOURNAL OF HEPATOLOGY
- Identification of the Serine 307 of LKB1 as a Novel Phosphorylation Site Essential for Its Nucleocytoplasmic Transport and Endothelial Cell Angiogenesis
- (2009) Z. Xie et al. MOLECULAR AND CELLULAR BIOLOGY
- Adenosine receptors in regulation of dendritic cell differentiation and function
- (2008) S. V. Novitskiy et al. BLOOD
- Phosphorylation of LKB1 at Serine 428 by Protein Kinase C-ζ Is Required for Metformin-Enhanced Activation of the AMP-Activated Protein Kinase in Endothelial Cells
- (2008) Zhonglin Xie et al. CIRCULATION
- Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation
- (2008) Lijian Hui et al. JOURNAL OF CLINICAL INVESTIGATION
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
- (2008) Heather R. Christofk et al. NATURE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo
- (2008) A Bessard et al. ONCOGENE
- Tumor-induced modulation of dendritic cell function
- (2007) E GOTTFRIED et al. CYTOKINE & GROWTH FACTOR REVIEWS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started